269 related articles for article (PubMed ID: 6600158)
1. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy.
Jaken S; Shupnik MA; Blumberg PM; Tashjian AH
Cancer Res; 1983 Jan; 43(1):11-4. PubMed ID: 6600158
[TBL] [Abstract][Full Text] [Related]
2. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
Jeng AY; Lichti U; Strickland JE; Blumberg PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
[TBL] [Abstract][Full Text] [Related]
3. Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells.
Jaken S; Tashjian AH; Blumberg PM
Cancer Res; 1981 Dec; 41(12 Pt 1):4956-60. PubMed ID: 6272986
[TBL] [Abstract][Full Text] [Related]
4. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
[TBL] [Abstract][Full Text] [Related]
5. Characterization of phorbol ester receptors and their down-modulation in GH4C1 rat pituitary cells.
Jaken S; Tashjian AH; Blumberg PM
Cancer Res; 1981 Jun; 41(6):2175-81. PubMed ID: 6786733
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
Blumberg PM; Delclos KB; Dunphy WG; Jaken S
Carcinog Compr Surv; 1982; 7():519-35. PubMed ID: 7039833
[TBL] [Abstract][Full Text] [Related]
7. Presence of specific binding sites for phorbol ester tumor promoters in human epidermal and dermal cells in culture but lack of down regulation in epidermal cells.
Chida K; Kuroki T
Cancer Res; 1983 Aug; 43(8):3638-42. PubMed ID: 6574816
[TBL] [Abstract][Full Text] [Related]
8. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
Greenebaum E; Nicolaides M; Eisinger M; Vogel RH; Weinstein IB
J Natl Cancer Inst; 1983 Mar; 70(3):435-41. PubMed ID: 6300498
[TBL] [Abstract][Full Text] [Related]
9. Phorbol ester binding to chemotactically responding and nonresponding Walker 256 carcinosarcoma cells.
Clarke PR; Varani J
Cancer Res; 1984 Nov; 44(11):4967-71. PubMed ID: 6593115
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
[TBL] [Abstract][Full Text] [Related]
11. Binding of phorbol esters to high-affinity sites on murine fibroblastic cells elicits a mitogenic response.
Collins MK; Rozengurt E
J Cell Physiol; 1982 Jul; 112(1):42-50. PubMed ID: 6286693
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the growth inhibition induced by tumor-promoting phorbol esters and of their receptor binding in A549 human lung carcinoma cells.
Gescher A; Reed DJ
Cancer Res; 1985 Sep; 45(9):4315-21. PubMed ID: 3861245
[TBL] [Abstract][Full Text] [Related]
13. Prevention of phorbol ester receptor down modulation in human myeloblastic leukemia ML-1 cells by differentiation-stimulating serum components.
Sakagami H; Hromchak R; Block A
Cancer Res; 1984 Aug; 44(8):3330-5. PubMed ID: 6331642
[TBL] [Abstract][Full Text] [Related]
14. Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cells.
Leach KL; Frost MM; Blumberg PM; Bressler JP
Cancer Lett; 1987 Aug; 36(2):139-47. PubMed ID: 3040225
[TBL] [Abstract][Full Text] [Related]
15. Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.
Weinberg JB; Misukonis MA; Goodwin BJ
Cancer Res; 1984 Mar; 44(3):976-80. PubMed ID: 6318990
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
Weinstein IB; Arcoleo J; Backer J; Jeffrey A; Hsiao WL; Gattoni-Celli S; Kirschmeier P; Okin E
Princess Takamatsu Symp; 1983; 14():59-74. PubMed ID: 6097583
[TBL] [Abstract][Full Text] [Related]
17. Highly lipophilic phorbol esters as inhibitors of specific [3H]phorbol 12,13-dibutyrate binding.
Sharkey NA; Blumberg PM
Cancer Res; 1985 Jan; 45(1):19-24. PubMed ID: 3855281
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptors interact with transforming growth factors produced by certain human tumor cells and are distinct from specific membrane receptors for phorbol and ingenol esters.
Todaro GJ; De Larco JE; Shoyab M
Carcinog Compr Surv; 1982; 7():443-62. PubMed ID: 6279294
[No Abstract] [Full Text] [Related]
19. Specific binding of [20-3H]12-deoxyphorbol 13-isobutyrate to phorbol ester receptor subclasses in mouse skin particulate preparations.
Dunn JA; Blumberg PM
Cancer Res; 1983 Oct; 43(10):4632-7. PubMed ID: 6309373
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of epidermal growth factor binding to mouse embryonal carcinoma cells by phorbol esters mediated by specific phorbol ester receptors.
Salomon DS
J Biol Chem; 1981 Aug; 256(15):7958-66. PubMed ID: 6267031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
